TherapeuticsMD Announces Fourth Quarter and Full-Year 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St mixed as benchmark Treasury yields reach 5%, oil takes a pause
- Oil slides following outreach to Iran to limit Houthis actions in Red Sea
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
TherapeuticsMD (TXMD) Misses Q4 EPS by 5c
March 2, 2021 7:12 AM ESTTherapeuticsMD (NASDAQ: TXMD) reported Q4 EPS of ($0.15), $0.05 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $22.6 million versus the consensus estimate of $21.89 million.
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.
... More